Asthma 1
Asthma 2
COPD 1
COPD 2
Devices
100

Preferred reliever strategy in modern asthma guidelines combining bronchodilation and anti-inflammatory effect

What is: PRN low dose ICS-formoterol

100

This LABA cannot be used PRN like formoterol because its onset is slower.

What is salmeterol?

100

Initial maintenance therapy for symptomatic COPD without frequent exacerbations

What is: A bronchodilator

100

Key vaccination strongly recommended in COPD to reduce exacerbation risk.

What are influenza and pneumococcal vaccines?

100

Device covering LABA/LAMA/ICS combination

What is: Trelegy Ellipta, Enerzair Breezhaler

200

This short acting bronchodilator is associated with tachycardia, tremors and palpilations

What is: SABA
200

Two key things to reassess before stepping up asthma therapy

What are adherence and inhaler technique? (± trigger control)

200

Blood eosinophil threshold warranting ICS therapy

What is: > 300 cells/uL

200

Most important non-drug intervention to slow COPD progression.

What is smoking cessation?

200
Inhalation device compatible with Aerochambers

What is: MDI

300

This short acting bronchodilator has a slower onset than it's short acting counterpart

What is: SAMA

300

Leukotriene receptor antagonist with neuropsychiatric warnings

What is montelukast?

300

Important ICS adverse effect risk in COPD

What is: pneumonia risk

300

Typical pharmacologic treatment during moderate COPD exacerbation besides bronchodilators.

What are systemic corticosteroids (± antibiotics if indicated)?

300

This inhaler type might not be compatible with a person with low coordination or dexterity

What is: Handihaler, Breezhaler

400

Uncontrolled asthma on low dose ICS-formoterol MART, what is the next common pharmacologic escalation?

What is: increase to medium dose of ICS-formoterol for maintenance

400

If asthma is controlled ≥3 months, guidelines suggest reducing this therapy first.

What is ICS dose (step-down)?

400

First pharmacologic escalation is symptoms persist on single long acting bronchodilator

What is: dual bronchodilator therapy (LABA/LAMA)

400

LU code criteria to be met for coverage of SITTs in COPD

COPD patient with history of exacerbations, ICS/LABA/LAMA is indicated/required

400

This inhaler type has audio/visual dose confirmation

What is: Genuair DPI

500

During early asthma exacerbation, some action plans recommend temporarily increasing this ICS medication dose up to this amount.

What is: quadrupling ICS dose

500

This SABA overuse threshold (canisters/year) signals poor asthma control and increased exacerbation risk in guidelines.

What is ≥3 SABA canisters per year?

500

High risk COPD exacerbation history per CTS definition

What is: 2+ moderate exacerbations or 1+ severe exacerbation

500

Reasons SAMA/SAMA combination (Combivent) might not be preferred as rescue in COPD

Not covered by ODB, cumulating anticholinergic side effects if LAMA is also added to regimen

500

This inhaler type doesn't require high inspiratory force

What is: Respimat, MDI (with spacer)

M
e
n
u